Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
o-decyl hydrogen thiocarbonate
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
O-Decyl Hydrogen Thiocarbonate is an organic compound with the molecular formula C11H22O2S. It consists of a decyl group (C10H21) attached to a thiocarbonate moiety characterized by a central carbon atom bonded to two oxygen atoms and one sulfur atom[1][2][3]. The compound is classified as an organic thiocarbonic acid derivative[3]. There is no evidence of clinical use or approved indications for this substance. It is considered experimental and has not been developed or marketed as a pharmaceutical drug[3].
- Other names
- O-Decyl Hydrogen Thiocarbonatedecyl sulfanylformatedecoxymethanethioic S-acid2qnxSCHEMBL5497475SCHEMBL-5497475SCHEMBL 5497475SCHEMBL25709707SCHEMBL-25709707SCHEMBL 25709707
Beyond the preview
Go deeper on o-decyl hydrogen thiocarbonate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on o-decyl hydrogen thiocarbonate.